References
- Sermer D, Pasqualucci L, Wendel HG, Melnick A and Younes A (2019) Emerging epigenetic-modulating therapies in lymphoma. Nat Rev Clin Oncol 16, 494-507 https://doi.org/10.1038/s41571-019-0190-8
- Shi Y, Dong M, Hong X et al (2015) Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma. Ann Oncol 26, 1766-1771 https://doi.org/10.1093/annonc/mdv237
- Ji MM, Huang YH, Huang JY et al (2018) Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified. Haematologica 103, 679-687 https://doi.org/10.3324/haematol.2017.182444
- Van Arnam JS, Lim MS and Elenitoba-Johnson KSJ (2018) Novel insights into the pathogenesis of T-cell lymphomas. Blood 131, 2320-2330 https://doi.org/10.1182/blood-2017-11-764357
- Pfister AS (2019) Emerging Role of the Nucleolar Stress Response in Autophagy. Front Cell Neurosci 13, 156 https://doi.org/10.3389/fncel.2019.00156
- Poillet-Perez L and White E (2019) Role of tumor and host autophagy in cancer metabolism. Genes Dev 33, 610-619 https://doi.org/10.1101/gad.325514.119
- Zhang H and McCarty N (2017) Tampering with cancer chemoresistance by targeting the TGM2-IL6-autophagy regulatory network. Autophagy 13, 627-628 https://doi.org/10.1080/15548627.2016.1271516
- Li Y, Zhou X, Zhang Y et al (2019) CUL4B regulates autophagy via JNK signaling in diffuse large B-cell lymphoma. Cell Cycle 18, 379-394 https://doi.org/10.1080/15384101.2018.1560718
- Yan J, Zhang J, Zhang X et al (2018) AEG-1 is involved in hypoxia-induced autophagy and decreases chemosensitivity in T-cell lymphoma. Mol Med 24, 35
- Treiber T, Treiber N and Meister G (2019) Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol 20, 5-20 https://doi.org/10.1038/s41580-018-0059-1
- Gebert LFR and MacRae IJ (2019) Regulation of microRNA function in animals. Nat Rev Mol Cell Biol 20, 21-37 https://doi.org/10.1038/s41580-018-0045-7
- Yao Y, Ma J, Xue Y et al (2015) MiR-449a exerts tumorsuppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein. Mol Oncol 9, 640-656 https://doi.org/10.1016/j.molonc.2014.11.003
- Sandbothe M, Buurman R, Reich N et al (2017) The microRNA-449 family inhibits TGF-beta-mediated liver cancer cell migration by targeting SOX4. J Hepatol 66, 1012-1021 https://doi.org/10.1016/j.jhep.2017.01.004
- Li F, Liang J and Bai L (2018) MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression. Biomed Pharmacother 103, 782-789 https://doi.org/10.1016/j.biopha.2018.04.101
- Sun AG, Meng FG and Wang MG (2017) CISD2 promotes the proliferation of glioma cells via suppressing beclin1mediated autophagy and is targeted by microRNA449a. Mol Med Rep 16, 7939-7948 https://doi.org/10.3892/mmr.2017.7642
- Cai Y, Jiang C, Zhu J et al (2019) miR-449a inhibits cell proliferation, migration, and inflammation by regulating high-mobility group box protein 1 and forms a mutual inhibition loop with Yin Yang 1 in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Res Ther 21, 134 https://doi.org/10.1186/s13075-019-1920-0
- Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375-2390 https://doi.org/10.1182/blood-2016-01-643569
- Sorigue M and Sancho JM (2019) Recent landmark studies in follicular lymphoma. Blood Rev 35, 68-80 https://doi.org/10.1016/j.blre.2019.03.006
- Argnani L, Broccoli A and Zinzani PL (2017) Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease. Cancer Treat Rev 61, 61-69 https://doi.org/10.1016/j.ctrv.2017.10.007
- Horwitz S, O'Connor OA, Pro B et al (2019) Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet 393, 229-240 https://doi.org/10.1016/S0140-6736(18)32984-2
- Zhang L, Li J, Ouyang L, Liu B and Cheng Y (2016) Unraveling the roles of Atg4 proteases from autophagy modulation to targeted cancer therapy. Cancer Lett 373, 19-26 https://doi.org/10.1016/j.canlet.2016.01.022
- Fu Y, Huang Z, Hong L et al (2019) Targeting ATG4 in Cancer Therapy. Cancers (Basel) 11, 649 https://doi.org/10.3390/cancers11050649
- Kurdi A, Cleenewerck M, Vangestel C et al (2017) ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice. Biochem Pharmacol 138, 150-162 https://doi.org/10.1016/j.bcp.2017.06.119
- Akin D, Wang SK, Habibzadegah-Tari P et al (2014) A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors. Autophagy 10, 2021-2035 https://doi.org/10.4161/auto.32229
- Huang T, Kim CK, Alvarez AA et al (2017) MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma. Cancer Cell 32, 840-855.e848 https://doi.org/10.1016/j.ccell.2017.11.005
- Zhang N, Wu Y, Lyu X et al (2017) HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells. Cancer Lett 409, 81-90 https://doi.org/10.1016/j.canlet.2017.08.039
- Yao L, Zhu Z, Wu J et al (2019) MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease. FASEB J 33, 8648-8665 https://doi.org/10.1096/fj.201900363r
- Sun W, Yi Y, Xia G et al (2019) Nrf2-miR-129-3p-mTOR Axis Controls an miRNA Regulatory Network Involved in HDACi-Induced Autophagy. Mol Ther 27, 1039-1050 https://doi.org/10.1016/j.ymthe.2019.02.010
- Xu J, Su Y, Xu A et al (2019) miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma. Mol Ther 27, 559-570 https://doi.org/10.1016/j.ymthe.2019.01.012
- Qu A, Sun M, Xu L et al (2019) Quantitative zeptomolar imaging of miRNA cancer markers with nanoparticle assemblies. Proc Natl Acad Sci U S A 116, 3391-3400 https://doi.org/10.1073/pnas.1810764116
- Bahmanpour Z, Sheervalilou R, Choupani J, Shekari Khaniani M, Montazeri V and Mansoori Derakhshan S (2019) A new insight on serum microRNA expression as novel biomarkers in breast cancer patients. J Cell Physiol 234, 19199-19211 https://doi.org/10.1002/jcp.28656
- Asano N, Matsuzaki J, Ichikawa M et al (2019) A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes. Nat Commun 10, 1299 https://doi.org/10.1038/s41467-019-09143-8